{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:20:14Z","timestamp":1793035214044,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/md.0000000000002476","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T17:15:27Z","timestamp":1452705327000},"page":"e2476","source":"Crossref","is-referenced-by-count":29,"title":["Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting"],"prefix":"10.1097","volume":"95","author":[{"given":"Zhihuang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-58-20210826","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting","volume":"358","author":"Hesketh","year":"2008","journal-title":"N Engl J Med"},{"key":"R2-58-20210826","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s00520-012-1448-1","article-title":"Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients\u2019 quality of life","volume":"20","author":"Fernandez-Ortega","year":"2012","journal-title":"Support Care Cancer"},{"key":"R3-58-20210826","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00520-006-0173-z","article-title":"Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings","volume":"15","author":"Cohen","year":"2007","journal-title":"Support Care Cancer"},{"key":"R4-58-20210826","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/annonc\/mdv138","article-title":"Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review","volume":"26","author":"Jordan","year":"2015","journal-title":"Ann Oncol"},{"key":"R5-58-20210826","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","article-title":"Incidence of chemotherapy-induced nausea and emesis after modern antiemetics","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer"},{"key":"R6-58-20210826","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/annonc\/mds021","article-title":"The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)","volume":"23","author":"Aapro","year":"2012","journal-title":"Ann Oncol"},{"key":"R7-58-20210826","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00520-014-2373-2","article-title":"Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries","volume":"23","author":"Hsieh","year":"2015","journal-title":"Support Care Cancer"},{"key":"R8-58-20210826","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JOP.2012.000816","article-title":"Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study","volume":"10","author":"Gilmore","year":"2014","journal-title":"J Oncol Pract"},{"key":"R9-58-20210826","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00520-014-2376-z","article-title":"Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice","volume":"23","author":"Kim","year":"2015","journal-title":"Support Care Cancer"},{"key":"R10-58-20210826","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1089\/jpm.2011.0527","article-title":"Medroxyprogesterone acetate for refractory emesis in cisplatin-treated patients","volume":"15","author":"Hata","year":"2012","journal-title":"J Palliat Med"},{"key":"R11-58-20210826","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/annonc\/mdq194","article-title":"Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference","volume":"21","author":"Roila","year":"2010","journal-title":"Ann Oncol"},{"key":"R12-58-20210826","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J Clin Oncol"},{"key":"R13-58-20210826","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00520-009-0737-9","article-title":"Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy","volume":"18","author":"Hesketh","year":"2010","journal-title":"Support Care Cancer"},{"key":"R14-58-20210826","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jpainsymman.2013.06.012","article-title":"Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study","volume":"47","author":"Molassiotis","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"R15-58-20210826","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/JCP.0b013e31824888a1","article-title":"Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting","volume":"32","author":"Yap","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"R16-58-20210826","first-page":"14","article-title":"Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting","volume":"11","author":"Dranitsaris","year":"2013","journal-title":"J Suppor Oncol"},{"key":"R17-58-20210826","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00520-013-1843-2","article-title":"Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting","volume":"21","author":"Molassiotis","year":"2013","journal-title":"Support Care Cancer"},{"key":"R18-58-20210826","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.3747\/co.19.1074","article-title":"Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting","volume":"19","author":"Bouganim","year":"2012","journal-title":"Curr Oncol"},{"key":"R19-58-20210826","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","article-title":"Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer","volume":"33","author":"Liang","year":"2015","journal-title":"J Clin Oncol"},{"key":"R20-58-20210826","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1200\/JCO.2013.49.8808","article-title":"Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials","volume":"32","author":"Hyman","year":"2014","journal-title":"J Clin Oncol"},{"key":"R21-58-20210826","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00520-013-2043-9","article-title":"Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial","volume":"22","author":"Hu","year":"2014","journal-title":"Support Care Cancer"},{"key":"R22-58-20210826","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00520-014-2372-3","article-title":"Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy: a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines","volume":"23","author":"Yu","year":"2015","journal-title":"Support Care Cancer"},{"key":"R23-58-20210826","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.1097\/MD.0000000000000760","article-title":"Prediction table and nomogram as tools for diagnosis of papillary thyroid carcinoma: combined analysis of ultrasonography, fine-needle aspiration biopsy, and BRAF V600E mutation","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine"},{"key":"R25-58-20210826","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/CCO.0b013e328352f6fb","article-title":"Management of highly emetogenic chemotherapy","volume":"24","author":"Warr","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"R26-58-20210826","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.08.049","article-title":"Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis","volume":"722","author":"Rojas","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"R27-58-20210826","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00520-014-2325-x","article-title":"Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers","volume":"23","author":"Van Laar","year":"2015","journal-title":"Support Care Cancer"},{"key":"R28-58-20210826","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1185\/03007995.2011.556603","article-title":"Likelihood of a subsequent chemotherapy-induced nausea and vomiting (CINV) event in patients receiving low, moderately or highly emetogenic chemotherapy (LEC\/MEC\/HEC)","volume":"27","author":"Schwartzberg","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"R29-58-20210826","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00520-015-2829-z","article-title":"Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial","volume":"24","author":"Abe","year":"2016","journal-title":"Support Care Cancer"},{"key":"R30-58-20210826","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1188\/13.ONF.163-170","article-title":"Ginger as an antiemetic modality for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis","volume":"40","author":"Lee","year":"2013","journal-title":"Oncol Nurs Forum"},{"key":"R31-58-20210826","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00520-011-1138-4","article-title":"Gabapentin for the prevention of chemotherapy-induced nausea and vomiting: a pilot study","volume":"20","author":"Cruz","year":"2012","journal-title":"Support Care Cancer"},{"key":"R32-58-20210826","doi-asserted-by":"crossref","first-page":"501","DOI":"10.6004\/jnccn.2004.0039","article-title":"Biobehavioral factors in chemotherapy-induced nausea and vomiting","volume":"2","author":"Roscoe","year":"2004","journal-title":"J Natl Compr Canc Netw"},{"key":"R33-58-20210826","doi-asserted-by":"crossref","first-page":"493","DOI":"10.6004\/jnccn.2012.0049","article-title":"Corticosteroids in the treatment of chemotherapy-induced nausea and vomiting","volume":"10","author":"Barbour","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"R34-58-20210826","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/cncr.21343","article-title":"Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy","volume":"104","author":"Herrstedt","year":"2005","journal-title":"Cancer"},{"key":"R35-58-20210826","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/cas.12146","article-title":"Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis","volume":"104","author":"Sekine","year":"2013","journal-title":"Cancer Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201601120-00058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T14:20:22Z","timestamp":1629987622000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201601120-00058"}},"subtitle":["Development and External Validation of a Nomogram in Cancer Patients Receiving Highly\/Moderately Emetogenic Chemotherapy"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002476","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}